Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...
Syngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects ...
Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...
Biocon advanced 2.41% to Rs 397.20 after its board is scheduled to meet on Monday, 27 January 2025, to consider and approve the raising of funds on a private placement basis.
India's Finance Minister will present the FY25-26 Union Budget on February 1, 2025. Analysts suggest focus on manufacturing, ...
Biocon stock price is poised for a fresh breakout from its consolidation range of 320-395, following nearly three and a half ...
Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...
As the US remains the top market for the Indian pharmaceutical industry, experts in India are now expecting opportunities for ...
Biocon's chairperson urges India's government to exempt cancer and chronic disease drugs from taxes to alleviate patient ...
India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...
Shaw, chairperson of Biocon Ltd, urges the Indian government to eliminate taxes on drugs for cancer and chronic diseases.
Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...